Healthcare
Live Price
Offline$14.75
+0.03% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
BELLUS Health Inc. (BLU) is a Healthcare stock with a market cap of $1.87B. The stock last traded around $14.74. Baseline metrics include revenue growth of 0.0%, EPS growth of +26.7%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +26.7%, free cash flow -41.0% with operating margin -486768.8% and ROIC -19.9%. Valuation already assumes a fairly strong business story at price/sales 116865.2. Stock Foundry combines BLU price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
BLU
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
BLU Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for BLU and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$25.7K
-4.1% YoY
FY Net Income
-$6.1M
+77.0% YoY
Free Cash Flow
-$7.5M
+70.2% YoY
Revenue Growth
+0.0%
EPS Growth
+26.7%
Gross Margin
-21967104.1%
Net Margin
-475500.0%
Income statement
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 16K | 16K | 15K | 27K | 26K |
| Gross Profit | -3.5B | -2.2B | -1.4B | -994M | 26K |
| Operating Income | -78M | -73M | -33M | -26M | -7M |
| EBITDA | -73M | -73M | -30M | -25M | -7M |
| Net Income | -76M | -71M | -32M | -26M | -6M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Cash & Equivalents | 87M | 150M | 49M | 19M | 11M |
| Total Assets | 408M | 310M | 153M | 96M | 39M |
| Total Liabilities | 17M | 18M | 6M | 8M | 2M |
| Shareholder Equity | 391M | 292M | 147M | 88M | 37M |
| Total Debt | 1M | 871K | 503K | 187K | 0 |
| Net Debt | -86M | -149M | -48M | -18M | -11M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
7M
+65.0% YoY
Capital Expenditures
1
+100.0% YoY
Free Cash Flow
7M
+70.2% YoY
Key ratios
Gross Margin
-21967104.1%
Operating Margin
-486768.8%
Net Margin
-475500.0%
ROE
-22.3%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.